Balanced news tone
News Sentiment
LLY sentiment intelligence
Eli Lilly and Company news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
News tone and price action are not far from neutral.
87/100 classification confidence.
directly relevant articles
high-authority source matches
-1.9% over one week, +4.5% over four weeks, trend active, and materially above fair value.
Eli Lilly & Co. (NYSE:LLY) Stands Out With High Growth Momentum and a Breakout Setup
Market Reaction
Balanced read
News tone and price action are not far from neutral.
Sentiment Mix
Positive, neutral, negative
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
News Tape
Relevant headlines
Eli Lilly & Co. (NYSE:LLY) Stands Out With High Growth Momentum and a Breakout Setup
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 17 Jul 2026 12:30
- Source
- ChartMill
UBS strongly resets Lilly stock target
- Tone
- Neutral 50/100
- Event
- Analyst action
- Published
- 16 Jul 2026 19:17
- Source
- thestreet.com
Eli Lilly Is Buying AtaiBeckley in $2.8 Billion Deal. What It Means for LLY Stock
- Tone
- Neutral 50/100
- Event
- Deals and strategy
- Published
- 16 Jul 2026 17:10
- Source
- Barchart.com
Eli Lilly deal to buy AtaiBeckley boosts psychedelic stocks
- Tone
- Positive 66/100
- Event
- Deals and strategy
- Published
- 16 Jul 2026 15:32
- Source
- Seeking Alpha
AtaiBeckley jumps 30% as Eli Lilly agrees to buy psychedelic firm for up to $3.8B (LLY:NYSE)
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 16 Jul 2026 10:57
- Source
- Seeking Alpha
Eli Lilly (LLY) Stock May Be Below Fair Value After FDA Cancer Drug Approval
- Tone
- Neutral 50/100
- Event
- Regulatory and legal
- Published
- 16 Jul 2026 10:42
- Source
- simplywall.st
Watch United Airlines Falls on Earnings; Eli Lilly Moves on Acquisition | Stock Movers
- Tone
- Negative 34/100
- Event
- Deals and strategy
- Published
- 16 Jul 2026 00:00
- Source
- Bloomberg.com
How to Buy Eli Lilly Stock (LLY) & Investment Guide
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 15 Jul 2026 13:47
- Source
- LiteFinance
What Lilly’s Peer-Beating Numbers Cost You
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 15 Jul 2026 10:39
- Source
- Trefis
Eli Lilly (LLY) Stock Dips While Market Gains: Key Facts
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 14 Jul 2026 21:45
- Source
- Market source
Is Lilly Stock On Track To Hit $2,090?
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 14 Jul 2026 14:10
- Source
- Forbes
Eli Lilly Stock (LLY) Opinions on Analyst Upgrades and Biotech Momentum
- Tone
- Neutral 50/100
- Event
- Analyst action
- Published
- 13 Jul 2026 17:34
- Source
- Quiver Quantitative
Why Is Eli Lilly (LLY) Stock Soaring Today
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 26 Jun 2026 07:00
- Source
- Market source
Eli Lilly and Bayer hit out at Germany’s spending on new medicines
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 23 Jun 2026 07:00
- Source
- Financial Times
Eli Lilly Stock - Analyst consensus stays bullish on weight-loss boom
- Tone
- Positive 66/100
- Event
- Analyst action
- Published
- 20 Jun 2026 07:00
- Source
- ad-hoc-news.de
Key facts: Eli Lilly builds ~$50B capacity; cuts Germany investment
- Tone
- Negative 34/100
- Event
- Market update
- Published
- 20 Jun 2026 07:00
- Source
- TradingView
Germany rethinking drug price reforms after Lilly, Boehringer withdraw investments: Reuters
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 15 Jun 2026 07:00
- Source
- BioSpace
Roche sticks to German investment after Eli Lilly cuts
- Tone
- Negative 34/100
- Event
- Market update
- Published
- 09 Jun 2026 07:00
- Source
- Reuters
Eli Lilly makes surprising retreat from major market
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 06 Jun 2026 07:00
- Source
- thestreet.com
Eli Lilly and Boehringer Ingelheim reduce major investments in Germany after new healthcare reforms
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 04 Jun 2026 07:00
- Source
- medwatch.com
Lilly, BioNTech Warn German Health Reforms Could Hurt Investment
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 04 Jun 2026 07:00
- Source
- Bloomberg.com
US pharma giant Eli Lilly is very unhappy with Germany; CEO calls its planned healthcare reform: Terrible
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 04 Jun 2026 07:00
- Source
- The Times of India
Eli Lilly Cuts Planned Germany Investment Amid Policy Concerns
- Tone
- Negative 34/100
- Event
- Market update
- Published
- 04 Jun 2026 07:00
- Source
- GuruFocus
Lilly and Boehringer roll back billions in German investments over health budget cuts
- Tone
- Negative 34/100
- Event
- Market update
- Published
- 04 Jun 2026 07:00
- Source
- BioSpace
Lilly, Boehringer to slash at least $1B each from planned investments in Germany
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 03 Jun 2026 07:00
- Source
- Fierce Pharma
Lilly halving planned €2.3B investment in Germany: CEO
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 03 Jun 2026 07:00
- Source
- Seeking Alpha
Lilly to halve planned €2.3 billion investment in Germany, CEO tells newspaper
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 03 Jun 2026 07:00
- Source
- Reuters
Lilly cuts Germany investment plan in half over healthcare reforms By Investing.com
- Tone
- Negative 34/100
- Event
- Market update
- Published
- 03 Jun 2026 07:00
- Source
- Investing.com
Eli Lilly & Co. stock (US5324571083): Q1 revenues surge 56% on obesity drug boom
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 11 May 2026 07:00
- Source
- ad-hoc-news.de
Eli Lilly Opens First Dedicated Genetic Medicine Facility
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 06 May 2026 07:00
- Source
- Pharmaceutical Commerce